Skip to application
All calculators and tools

Preparation. Administration. Evidence.

IV Dilution &
Medication Reference

Search 255 medications, read preserved historical references, and inspect separately reviewed preparation statements. Full monograph updates remain pending.

Version 6.4Release date 2026-11-04For healthcare professionals
Back to resultsA-Z list

Medication reference

Hydralazine

Monograph awaiting updateThis monograph will be updated in the future.

Jump to a section
Search DailyMed products (opens in a new tab)

Historical source. Current clinical review is incomplete. This monograph will be updated in the future.

Hydralazine (opens in a new tab)Original source URL: https://globalrph.com/dilution/hydralazine/ | Retrieved 2026-11-04

Source dates, location and integrity

This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.

Original source URL
https://globalrph.com/dilution/hydralazine/ (opens in a new tab)
Source date
Not established in the retrieved source
Retrieved
2026-11-04T19:46:33.974212+00:00
Source location
div.post-content
Packaged content SHA-256
b72590a88fb8565a14e119f7dbffc9bb3d308e69a0243366a330fa418381b69f
Original response SHA-256
50ff0d35532f9e3511fc0a77d50cbc3b70d95dce89e34d107328d4c34635c456
Source body SHA-256
89455951a85e195c27e2c345a9ca8bffbeb6da67078dbf2a828a82c9744736bd

HYDRALAZINE
The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.

Usual Diluents
NS

Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate]
[0 to 20 mg] [50 ml] [30 min]
[21 to 40 mg] [100 ml] [30 min]
[>40 mg] [250 ml] [60 min or longer]

Monitor BP q5min during initial infusion.

Stability / Miscellaneous
Manufacturer recommends IM or IV push.

Usual dosage: 10 to 40 mg IV q4-6h prn. May be given q20-30 minutes (until adequate response) for the treatment of severe hypertension. IV push (rate): 10 mg/min.

Label: Do not refrigerate. Stability: 24 hours room temperature.

DOSAGE AND ADMINISTRATION
When there is urgent need, therapy in the hospitalized patient may be initiated intramuscularly or as a rapid intravenous bolus injection directly into the vein. Hydralazine hydrochloride injection should be used only when the drug cannot be given orally. The usual dose is 20-40 mg, repeated as necessary.

Certain patients (especially those with marked renal damage) may require a lower dose. Blood pressure should be checked frequently. It may begin to fall within a few minutes after injection, with the average maximal decrease occurring in 10-80 minutes. In cases where there has been increased intracranial pressure, lowering the blood pressure may increase cerebral ischemia. Most patients can be transferred to oral hydralazine hydrochloride within 24-48 hours.

The product should be used immediately after the vial is opened. It should not be added to infusion solutions. Hydralazine hydrochloride injection may discolor upon contact with metal; discolored solutions should be discarded.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

Source: [package insert]

Open this historical article on its own

Product identifiers and clinical review status

This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.

Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.

What remains to be completed
  • Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
  • Clinically reviewed, individually identified statements with two exact source mappings
  • Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
  • Renal-function methods and dialysis/CRRT modality review where applicable
  • Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation

Supplemental historical fields

Restored-data provenance and review notes

Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.

Current review annotations for historical renal, dialysis, mechanism, and product fieldsSeparate renal reference: Open Renal Dosing Master (opens in a new tab)
Renal
Status
not_locally_normalized
Original classification
current_label_review_required
Entries
    General note
    Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
    Dialysis
    Status
    no_local_structured_regimen
    Entries
      General note
      Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
      Mechanisms
      • Source kind
        first_look
        Local pointer
        /mechanism
        Original level
        drug_specific
        Provenance classification
        historical_drug_specific_uncorroborated
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        Not recorded
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      Future update
      Status
      pending_review
      Message
      This monograph will be updated in the future as current exact-product and claim-level review is completed.
      Source unavailable
      false
      Reason
      The historical content is restored; comprehensive contemporary verification remains incomplete.
      Historical first look: uses, mechanism, dosing context, and administration

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      hydralazine
      Source IDH51-4B1B378E624BE7F936F31EF0
      Generic name
      Hydralazine
      Source IDH51-6D9A1EB06E7DC3D81D68E1A5
      Class
      Cardiovascular and vasoactive
      Source IDH51-26302D5CA588492134E9457C
      Subclass
      Direct vasodilator
      Source IDH51-FCEAFF54EFEE1095316D1396
      Primary uses
      1. Selected severe hypertension including pregnancy-related protocols
        Source IDH51-596CAD04050F648D9844CA0A
      Mechanism
      Directly relaxes arteriolar smooth muscle; the precise intracellular mechanism remains incompletely defined.
      Source IDH51-9DD0AB286DBC38B6F220D334
      Mechanism level
      drug_specific
      Source IDH51-0D4A30B58F2D7FE4B1C066F8
      Basic dosing orientation
      Adult / Obstetric | Common adult dose 5 to 10 mg; obstetric protocol may differ | Common adult dose 5 to 10 mg; obstetric protocol may differ | Patient- and indication-specific | See current package insert | IV push
      Source IDH51-3680D16E6E86D52B92E0A58E
      Administration orientation
      Slow IV over 1 to 2 minutes; 20 mg/mL after reconstitution or diluted; Slow IV over 1 to 2 minutes
      Source IDH51-5A2B30430598D817920E3E76
      Renal and population orientation
      Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
      Source IDH51-BACB9C45B432FF2B9778B1BF
      Key safety orientation
      1. Hypotension, reflex tachycardia, headache, and myocardial ischemia.
        Source IDH51-ADDD5F3803E4193935BECE9E
      Coverage path
      structured_local_snapshot
      Source IDH51-709196DB5898CA016F83F876
      Coverage path label
      Structured GlobalRPh route snapshot
      Source IDH51-FBAA6AE4AE5D315CCFF1012D
      Legacy title
      Hydralazine
      Source IDH51-54E6C2C9D462B40150B6D029
      Review note
      First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
      Source IDH51-8F8CA484967FBD7C9EC11D91
      Search text
      Hydralazine Cardiovascular and vasoactive Direct vasodilator Selected severe hypertension including pregnancy-related protocols Directly relaxes arteriolar smooth muscle; the precise intracellular mechanism remains incompletely defined. Adult / Obstetric | Common adult dose 5 to 10 mg; obstetric protocol may differ | Common adult dose 5 to 10 mg; obstetric protocol may differ | Patient- and indication-specific | See current package insert | IV push Slow IV over 1 to 2 minutes; 20 mg/mL after reconstitution or diluted; Slow IV over 1 to 2 minutes Renal dosing status has not been locally normalized; use the current package insert before ordering or administration. Hypotension, reflex tachycardia, headache, and myocardial ischemia. Structured GlobalRPh route snapshot
      Source IDH51-5124F4A00A2FC3DCFCAD08CE
      Official access mode
      search
      Source IDH51-453C9F86E6F698FCF504C688
      Official search query
      Hydralazine
      Source IDH51-2628DBC41CA8DF2CD774E0F7
      Official access reason
      A source-backed DailyMed search is available; select and confirm the exact IV product.
      Source IDH51-6EDE1D6EF36345E4E3A54BA5

      No separate structured rows were bundled for preparation, continuous infusion, dialysis, CRRT. Historical article content and source links may cover these topics.

      Historical IV-push guidance

      Recovered v5.1 source content; historical, awaiting current review.

      PopulationDose scopeConcentrationRateStatusNotes
      Source IDH51-8EF5C38E778B9B255A2C27C9
      Adult / Obstetric
      Source IDH51-EF419575363A2C4839C84FF3
      		Common adult dose 5 to 10 mg; obstetric protocol may differ
      Source IDH51-5AC7124C9A3A3EE93C187DAB
      		20 mg/mL after reconstitution or diluted
      Source IDH51-51BEC35198E0EDCE8C3F4575
      		Slow IV over 1 to 2 minutes
      Source IDH51-3874BFF9E843B5315E653336
      		Use only when ordered and supported by current labeling or institutional policy
      Source IDH51-545E33E51ABF6D75327F3BC4
      		Because response can be delayed and prolonged, avoid stacking doses before adequate reassessment.
      Source IDH51-F9BDD5A9AF182B0D4E78D38B

      Historical indication and population dosing

      Recovered tables and source-separated snapshots; full clinical revalidation remains pending.

      Existing dose and route snapshots

      RoutePopulationIndicationDoseIntervalDurationAdministrationSource levelNotes
      Source IDH51-C60D7A13A29ECBE047306F57
      IV push
      Source IDH51-F48013F4E2D26A9F47200711
      		Adult / Obstetric
      Source IDH51-9ADA1CA46838BFD0A3224FF6
      		Common adult dose 5 to 10 mg; obstetric protocol may differ
      Source IDH51-55A725445A2C4DC91E455E43
      		Common adult dose 5 to 10 mg; obstetric protocol may differ
      Source IDH51-843968BD824942A57D6ABC9B
      		Patient- and indication-specific
      Source IDH51-3ECFE534BEFA65BEF78F5D98
      		See current package insert
      Source IDH51-8E771F545513F5C97441230A
      		Slow IV over 1 to 2 minutes
      Source IDH51-739AF6220B65BAC3177C6DDF
      		Existing GlobalRPh IV push snapshot
      Source IDH51-028460641BA8EF0BC8FA5F25
      		Use only when ordered and supported by current labeling or institutional policy Because response can be delayed and prolonged, avoid stacking doses before adequate reassessment.
      Source IDH51-05EB261F3D1253DB43847EE9

      Historical renal-function guidance

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      Classification
      current_label_review_required
      Source IDH51-5F681BB7E80AF0A94E575DA2
      Summary
      Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
      Source IDH51-B7BBAE6A0A54690FA156CD39
      Method note
      Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
      Source IDH51-EFB52DE2CBDF9D080030D072

      Historical Common IV uses

      Recovered v5.1 source content; historical, awaiting current review.

      1. Selected severe hypertension including pregnancy-related protocols
        Source IDH51-B4A73BEBF5679C580C5C8E05

      Historical Warnings and safeguards

      Recovered v5.1 source content; historical, awaiting current review.

      1. Hypotension, reflex tachycardia, headache, and myocardial ischemia.
        Source IDH51-55A86D51F1C3E559C368A3B9

      Historical Monitoring

      Recovered v5.1 source content; historical, awaiting current review.

      1. Frequent blood pressure and heart rate
        Source IDH51-F46B962037919050C602F271
      Other recovered source fields and original editorial metadata

      Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.

      Catalog source fields

      Id
      hydralazine
      Source IDH51-0E93957143793506E828239B
      Generic name
      Hydralazine
      Source IDH51-E5CF37411B76129403446117
      Brand names
      1. Apresoline
        Source IDH51-7F5C81A67581764859B8BD7C
      Class
      Cardiovascular and vasoactive
      Source IDH51-6737D4F309B3D0B724588E4B
      Subclass
      Direct vasodilator
      Source IDH51-349DAD6065DC2B408FE31DFD
      Summary
      Intermittent IV vasodilator with unpredictable magnitude and duration of blood-pressure reduction.
      Source IDH51-E1C7E81DEE3D954E3712FA4A
      Populations
      1. Adult
        Source IDH51-3D4BCBB930DAC3FC6FB2A17A
      2. Obstetric
        Source IDH51-18A9C7D295524A278F296568
      Evidence tier
      IV push safety normalization - verify stocked product
      Source IDH51-AD4273CCBC9948FF769DE9D3
      High alert
      true
      Source IDH51-A756846028FC8B1867B74782
      Hazardous
      false
      Source IDH51-56CB892E2DFEF9EEF3807E49
      Status
      Active
      Source IDH51-941C83B91D62CF94E9DF1FFB
      Reviewed
      2026-08-29
      Source IDH51-6D91222C407B1C5709126B4C
      Version added
      1.2
      Source IDH51-310F00AAEDB5454FDFC56FE3
      Sources
      LabelUrlKind
      Source IDH51-08A5BC02A8099D943B6708AF
      DailyMed label search
      Source IDH51-960FB2589EA6E55A659AB175
      		https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Hydralazine (opens in a new tab)
      Source IDH51-A6E44C506E646B3EBB060847
      		Primary
      Source IDH51-518E445F596F9EFAD63BC3C3
      Source IDH51-9A5C69BED58AD75554DED94B
      GlobalRPh legacy IV dilution monograph
      Source IDH51-5703ABAB6E74DEC16797F7CA
      		legacy:auto
      Source IDH51-3CFB4778EB12647D570BA51A
      		Legacy
      Source IDH51-94E0A6069082EFC4D07CA05A
      Legacy title
      Hydralazine
      Source IDH51-EA66804263DD8EC268A8B118
      Clinical release verification
      Audit version
      3.4
      Source IDH51-2BEF25C5E7BCA4EDA5632776
      Audited on
      2026-08-30
      Source IDH51-DC5D3C0E6694053A7B9AF87E
      Level
      amber
      Source IDH51-FB84F4AE55357FFAFD11BC47
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-E5D778FBFF0E17C0D782015F
      Exact current label candidate
      false
      Source IDH51-D709338973783C245158C9A3
      Numeric support ratio
      0
      Source IDH51-0C8BB3611679111442558888
      Reference url count
      1
      Source IDH51-D04306727C088E061B1FD499
      Broken reference count
      0
      Source IDH51-ED9A106B127005D1428EE301
      Point of use confirmation required
      true
      Source IDH51-A238F4DCC623D7508910E859
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-FE17E961A8DDB3F69C190301

      Dosing source fields

      Id
      hydralazine
      Source IDH51-3C84473FE4A68EBCA742E587
      Generic name
      Hydralazine
      Source IDH51-F098C2E80B6C3916009DF3F1
      Coverage status
      direct_official_label_access_plus_local_snapshot
      Source IDH51-85FC0D0D42CDE4CC73AB2F82
      Package insert
      Query name
      Hydralazine
      Source IDH51-1D3590EC7F5DACD6559B09D1
      Product and route must match
      true
      Source IDH51-692FA438FD681CC1CB275284
      Live current label enabled
      false
      Source IDH51-8B4F2C1404433FCC5B73F879
      Source priority
      Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
      Source IDH51-D92B1172C568267887D58311
      Direct official label access enabled
      true
      Source IDH51-D3492103AFF76E39080BBA58
      Outbound server request required
      false
      Source IDH51-233260F04D86C8912D510DCD
      Local summary status
      not_bundled
      Source IDH51-F65C159E499329A5219E6C79
      Clinical review
      Locally normalized
      false
      Source IDH51-4F236A6E879EA88B71729C43
      Reviewed
      2026-08-29
      Source IDH51-AA27E78D4454885C3977B0B5
      Status
      Direct official package-insert access enabled; indication-specific local normalization pending.
      Source IDH51-9843A65A6EBB3F3730EE2248
      Clinical release verification
      Audit version
      3.4
      Source IDH51-953097C56BE4F7C7BA6E76F8
      Audited on
      2026-08-30
      Source IDH51-E0AD146C006DFC764C658050
      Level
      amber
      Source IDH51-6CCD4A8C6AEA35D145E3A0FB
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-881BE93C553A50C9F565D96B
      Exact current label candidate
      false
      Source IDH51-F324DF2EF93810CFE7D2527C
      Numeric support ratio
      0
      Source IDH51-3DE633625503D181815C3F94
      Reference url count
      1
      Source IDH51-7B2ED3BE5F5DA85404A505CC
      Broken reference count
      0
      Source IDH51-7B045064B9837C558F12CCA1
      Point of use confirmation required
      true
      Source IDH51-B91F8ADA46E0CAC970CC10F0
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-4718D49D6C114A50C5DD9CD1
      Historical preparation assessment

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      hydralazine
      Source IDH51-D3951A94293E7C8B720A7B03
      Name
      Hydralazine
      Source IDH51-B8736EDE542131858EFE7F3D
      Brands
      Apresoline
      Source IDH51-C3D54189310D274A686589A7
      Therapeutic class
      Cardiovascular and vasoactive
      Source IDH51-A4DCDEDB53D56971AE8F58F6
      Review version
      3.1
      Source IDH51-F91E31EE26009DA38BB7B533
      Review date
      2026-08-30
      Source IDH51-570D558FA7F67B897B645CD9
      Release status
      structured_record_current_label_not_confirmed
      Source IDH51-56D1381B60C3C232EDD0181D
      Market status
      Status
      no_current_us_iv_spl_confirmed
      Source IDH51-B12FD883A8F824612E59C743
      Basis
      No high-confidence current IV SPL was automatically selected; legacy information is segregated
      Source IDH51-5349E623C228D9D0A9EDF5C5
      Ten point assessment
      Exact formulation
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-34976520EC52CC8451D74341
      Reconstitution concentration
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-88001F7E9F6523858825FA93
      Maximum or recommended final concentration
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-B83B62718F111A39D0CF24A8
      Appropriate standardized containers
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-0831A5AF2C01D86BE3A7D8F4
      Adult dosing range
      Common adult dose 5 to 10 mg; obstetric protocol may differ Common adult dose 5 to 10 mg; obstetric protocol may differ
      Source IDH51-57A274C54B3CC440CC39E9D4
      Pediatric dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-2C2BB2553E1508640E512136
      Neonatal dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-F46CCA0106378AF8263F7516
      Infusion time
      Slow IV over 1 to 2 minutes
      Source IDH51-13DDC5C381D7214E4238E693
      Fluid restriction alternatives
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-15F6D387D55B8342502DA78A
      Current manufacturer labeling
      Match confidence
      unresolved
      Source IDH51-562ED4BC98E51C5EC58D4C0A
      Field provenance
      Exact formulation
      Primary
      not_found
      Source IDH51-AB847D2B9ED9E9BFCDEEB4E3
      Reconstitution concentration
      Primary
      not_found
      Source IDH51-F1C49AD1850DFA3B8984FE5C
      Maximum or recommended final concentration
      Primary
      not_found
      Source IDH51-F3A33DD2C0C5606A3CCFCE31
      Appropriate standardized containers
      Primary
      not_found
      Source IDH51-94733CF723BE52C1E7B5C721
      Adult dosing range
      Primary
      existing_structured_record
      Source IDH51-48E42E5A860AC568DC1A6C1A
      Pediatric dosing range
      Primary
      not_found
      Source IDH51-DA0FDD80DBFC4A158D42A505
      Neonatal dosing range
      Primary
      not_found
      Source IDH51-600150C80E37F7ECF723F825
      Infusion time
      Primary
      existing_structured_record
      Source IDH51-0D1BBFFBC0844D071C6D13C8
      Fluid restriction alternatives
      Primary
      not_found
      Source IDH51-6815A4FDA5D994495156194B
      Current manufacturer labeling
      Primary
      DailyMed search gateway
      Source IDH51-01F53AED04EE7BEE446866FF
      Population applicability
      Adult
      Applicability
      supported_or_source_present
      Source IDH51-4E59DD526DB76395067FE216
      Guide generation allowed
      true
      Source IDH51-E0DCAD75B39798FBB315C1EC
      Pediatric
      Applicability
      not_established
      Source IDH51-B9BF5E633D6C81F575B73B0C
      Guide generation allowed
      false
      Source IDH51-4B498132FD16B13D8E61A835
      Neonatal
      Applicability
      not_established
      Source IDH51-B478047EA6625F02AB9A5C26
      Guide generation allowed
      false
      Source IDH51-30864EA284D9AD14355649C8
      Route presence
      Structured dilution
      true
      Source IDH51-00435B0DBC378310594F2395
      Iv push
      true
      Source IDH51-0E41839CAB0E9B3E06811640
      Continuous infusion
      false
      Source IDH51-909C381E8F5FB575FDAFA4EC
      Pediatric source
      false
      Source IDH51-4E1404DD3BE2C7D0BAD52E32
      Neonatal source
      false
      Source IDH51-A3B4B11BD6D3B54220A5ADA2
      Legacy reference
      Status
      not_available
      Source IDH51-0516F9EF6D5FB97B8DCCFF67
      Label resolution
      Status
      build_environment_network_unavailable
      Source IDH51-DBC98D1F860DD7D6F3A5D035
      Source files
      1. catalog.json
        Source IDH51-CAA851C71E42FED6AAB7F745
      2. dosing.json
        Source IDH51-AECBB4D7A650262EB6F939A2
      3. legacy-map.json
        Source IDH51-DD486FC38AE3E1B3EC12B517
      4. new-in-v1.2.json
        Source IDH51-20608A3F5BD9EF6114012154
      Clinical release note
      Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
      Source IDH51-99ADEAF7C6ACB7D90CFB2FE7
      Historical statement IDs and source locations

      These IDs identify recovered source units. They are not evidence-qualified clinical claims.

      Historical IDOriginal source locationStatus
      H51-0E93957143793506E828239Bcatalog.json
      /records/122/id      		Historical; current review incomplete
      H51-E5CF37411B76129403446117catalog.json
      /records/122/generic_name      		Historical; current review incomplete
      H51-7F5C81A67581764859B8BD7Ccatalog.json
      /records/122/brand_names/0      		Historical; current review incomplete
      H51-6737D4F309B3D0B724588E4Bcatalog.json
      /records/122/class      		Historical; current review incomplete
      H51-349DAD6065DC2B408FE31DFDcatalog.json
      /records/122/subclass      		Historical; current review incomplete
      H51-E1C7E81DEE3D954E3712FA4Acatalog.json
      /records/122/summary      		Historical; current review incomplete
      H51-B4A73BEBF5679C580C5C8E05catalog.json
      /records/122/common_uses/0      		Historical; current review incomplete
      H51-8EF5C38E778B9B255A2C27C9catalog.json
      /records/122/iv_push/0      		Historical; current review incomplete
      H51-EF419575363A2C4839C84FF3catalog.json
      /records/122/iv_push/0/population      		Historical; current review incomplete
      H51-5AC7124C9A3A3EE93C187DABcatalog.json
      /records/122/iv_push/0/dose_scope      		Historical; current review incomplete
      H51-51BEC35198E0EDCE8C3F4575catalog.json
      /records/122/iv_push/0/concentration      		Historical; current review incomplete
      H51-3874BFF9E843B5315E653336catalog.json
      /records/122/iv_push/0/rate      		Historical; current review incomplete
      H51-545E33E51ABF6D75327F3BC4catalog.json
      /records/122/iv_push/0/status      		Historical; current review incomplete
      H51-F9BDD5A9AF182B0D4E78D38Bcatalog.json
      /records/122/iv_push/0/notes      		Historical; current review incomplete
      H51-55A86D51F1C3E559C368A3B9catalog.json
      /records/122/warnings/0      		Historical; current review incomplete
      H51-F46B962037919050C602F271catalog.json
      /records/122/monitoring/0      		Historical; current review incomplete
      H51-3D4BCBB930DAC3FC6FB2A17Acatalog.json
      /records/122/populations/0      		Historical; current review incomplete
      H51-18A9C7D295524A278F296568catalog.json
      /records/122/populations/1      		Historical; current review incomplete
      H51-AD4273CCBC9948FF769DE9D3catalog.json
      /records/122/evidence_tier      		Historical; current review incomplete
      H51-A756846028FC8B1867B74782catalog.json
      /records/122/high_alert      		Historical; current review incomplete
      H51-56CB892E2DFEF9EEF3807E49catalog.json
      /records/122/hazardous      		Historical; current review incomplete
      H51-941C83B91D62CF94E9DF1FFBcatalog.json
      /records/122/status      		Historical; current review incomplete
      H51-6D91222C407B1C5709126B4Ccatalog.json
      /records/122/reviewed      		Historical; current review incomplete
      H51-310F00AAEDB5454FDFC56FE3catalog.json
      /records/122/version_added      		Historical; current review incomplete
      H51-08A5BC02A8099D943B6708AFcatalog.json
      /records/122/sources/0      		Historical; current review incomplete
      H51-960FB2589EA6E55A659AB175catalog.json
      /records/122/sources/0/label      		Historical; current review incomplete
      H51-A6E44C506E646B3EBB060847catalog.json
      /records/122/sources/0/url      		Historical; current review incomplete
      H51-518E445F596F9EFAD63BC3C3catalog.json
      /records/122/sources/0/kind      		Historical; current review incomplete
      H51-9A5C69BED58AD75554DED94Bcatalog.json
      /records/122/sources/1      		Historical; current review incomplete
      H51-5703ABAB6E74DEC16797F7CAcatalog.json
      /records/122/sources/1/label      		Historical; current review incomplete
      H51-3CFB4778EB12647D570BA51Acatalog.json
      /records/122/sources/1/url      		Historical; current review incomplete
      H51-94E0A6069082EFC4D07CA05Acatalog.json
      /records/122/sources/1/kind      		Historical; current review incomplete
      H51-EA66804263DD8EC268A8B118catalog.json
      /records/122/legacy_title      		Historical; current review incomplete
      H51-2BEF25C5E7BCA4EDA5632776catalog.json
      /records/122/clinical_release_verification/audit_version      		Historical; current review incomplete
      H51-DC5D3C0E6694053A7B9AF87Ecatalog.json
      /records/122/clinical_release_verification/audited_on      		Historical; current review incomplete
      H51-FB84F4AE55357FFAFD11BC47catalog.json
      /records/122/clinical_release_verification/level      		Historical; current review incomplete
      H51-E5D778FBFF0E17C0D782015Fcatalog.json
      /records/122/clinical_release_verification/release_gate      		Historical; current review incomplete
      H51-D709338973783C245158C9A3catalog.json
      /records/122/clinical_release_verification/exact_current_label_candidate      		Historical; current review incomplete
      H51-B1BE47FF2BB8E3780D28321Bcatalog.json
      /records/122/clinical_release_verification/selected_setid      		Historical; current review incomplete
      H51-7BC2CD977E16F8F9A876E62Bcatalog.json
      /records/122/clinical_release_verification/selected_label_title      		Historical; current review incomplete
      H51-0C8BB3611679111442558888catalog.json
      /records/122/clinical_release_verification/numeric_support_ratio      		Historical; current review incomplete
      H51-D04306727C088E061B1FD499catalog.json
      /records/122/clinical_release_verification/reference_url_count      		Historical; current review incomplete
      H51-ED9A106B127005D1428EE301catalog.json
      /records/122/clinical_release_verification/broken_reference_count      		Historical; current review incomplete
      H51-A238F4DCC623D7508910E859catalog.json
      /records/122/clinical_release_verification/point_of_use_confirmation_required      		Historical; current review incomplete
      H51-FE17E961A8DDB3F69C190301catalog.json
      /records/122/clinical_release_verification/note      		Historical; current review incomplete
      H51-45477CFD60DFA6967A3C5A96catalog.json
      /records/122/clinical_release_verification/dailymed_search_url      		Historical; current review incomplete
      H51-3C84473FE4A68EBCA742E587dosing.json
      /records/122/id      		Historical; current review incomplete
      H51-F098C2E80B6C3916009DF3F1dosing.json
      /records/122/generic_name      		Historical; current review incomplete
      H51-85FC0D0D42CDE4CC73AB2F82dosing.json
      /records/122/coverage_status      		Historical; current review incomplete
      H51-1D3590EC7F5DACD6559B09D1dosing.json
      /records/122/package_insert/query_name      		Historical; current review incomplete
      H51-893E9A1486DC6709F35D2436dosing.json
      /records/122/package_insert/preferred_setid      		Historical; current review incomplete
      H51-692FA438FD681CC1CB275284dosing.json
      /records/122/package_insert/product_and_route_must_match      		Historical; current review incomplete
      H51-8B4F2C1404433FCC5B73F879dosing.json
      /records/122/package_insert/live_current_label_enabled      		Historical; current review incomplete
      H51-D92B1172C568267887D58311dosing.json
      /records/122/package_insert/source_priority      		Historical; current review incomplete
      H51-D3492103AFF76E39080BBA58dosing.json
      /records/122/package_insert/direct_official_label_access_enabled      		Historical; current review incomplete
      H51-233260F04D86C8912D510DCDdosing.json
      /records/122/package_insert/outbound_server_request_required      		Historical; current review incomplete
      H51-F65C159E499329A5219E6C79dosing.json
      /records/122/package_insert/local_summary_status      		Historical; current review incomplete
      H51-5F681BB7E80AF0A94E575DA2dosing.json
      /records/122/renal/classification      		Historical; current review incomplete
      H51-B7BBAE6A0A54690FA156CD39dosing.json
      /records/122/renal/summary      		Historical; current review incomplete
      H51-EFB52DE2CBDF9D080030D072dosing.json
      /records/122/renal/method_note      		Historical; current review incomplete
      H51-C60D7A13A29ECBE047306F57dosing.json
      /records/122/existing_route_snapshots/0      		Historical; current review incomplete
      H51-F48013F4E2D26A9F47200711dosing.json
      /records/122/existing_route_snapshots/0/route      		Historical; current review incomplete
      H51-9ADA1CA46838BFD0A3224FF6dosing.json
      /records/122/existing_route_snapshots/0/population      		Historical; current review incomplete
      H51-55A725445A2C4DC91E455E43dosing.json
      /records/122/existing_route_snapshots/0/indication      		Historical; current review incomplete
      H51-843968BD824942A57D6ABC9Bdosing.json
      /records/122/existing_route_snapshots/0/dose      		Historical; current review incomplete
      H51-3ECFE534BEFA65BEF78F5D98dosing.json
      /records/122/existing_route_snapshots/0/interval      		Historical; current review incomplete
      H51-8E771F545513F5C97441230Adosing.json
      /records/122/existing_route_snapshots/0/duration      		Historical; current review incomplete
      H51-739AF6220B65BAC3177C6DDFdosing.json
      /records/122/existing_route_snapshots/0/administration      		Historical; current review incomplete
      H51-028460641BA8EF0BC8FA5F25dosing.json
      /records/122/existing_route_snapshots/0/source_level      		Historical; current review incomplete
      H51-05EB261F3D1253DB43847EE9dosing.json
      /records/122/existing_route_snapshots/0/notes      		Historical; current review incomplete
      H51-4F236A6E879EA88B71729C43dosing.json
      /records/122/clinical_review/locally_normalized      		Historical; current review incomplete
      H51-AA27E78D4454885C3977B0B5dosing.json
      /records/122/clinical_review/reviewed      		Historical; current review incomplete
      H51-9843A65A6EBB3F3730EE2248dosing.json
      /records/122/clinical_review/status      		Historical; current review incomplete
      H51-953097C56BE4F7C7BA6E76F8dosing.json
      /records/122/clinical_release_verification/audit_version      		Historical; current review incomplete
      H51-E0AD146C006DFC764C658050dosing.json
      /records/122/clinical_release_verification/audited_on      		Historical; current review incomplete
      H51-6CCD4A8C6AEA35D145E3A0FBdosing.json
      /records/122/clinical_release_verification/level      		Historical; current review incomplete
      H51-881BE93C553A50C9F565D96Bdosing.json
      /records/122/clinical_release_verification/release_gate      		Historical; current review incomplete
      H51-F324DF2EF93810CFE7D2527Cdosing.json
      /records/122/clinical_release_verification/exact_current_label_candidate      		Historical; current review incomplete
      H51-9FA61EAF04CCB5AC9AF9513Fdosing.json
      /records/122/clinical_release_verification/selected_setid      		Historical; current review incomplete
      H51-1DF8D066426980B52B2BCD96dosing.json
      /records/122/clinical_release_verification/selected_label_title      		Historical; current review incomplete
      H51-3DE633625503D181815C3F94dosing.json
      /records/122/clinical_release_verification/numeric_support_ratio      		Historical; current review incomplete
      H51-7B2ED3BE5F5DA85404A505CCdosing.json
      /records/122/clinical_release_verification/reference_url_count      		Historical; current review incomplete
      H51-7B045064B9837C558F12CCA1dosing.json
      /records/122/clinical_release_verification/broken_reference_count      		Historical; current review incomplete
      H51-B91F8ADA46E0CAC970CC10F0dosing.json
      /records/122/clinical_release_verification/point_of_use_confirmation_required      		Historical; current review incomplete
      H51-4718D49D6C114A50C5DD9CD1dosing.json
      /records/122/clinical_release_verification/note      		Historical; current review incomplete
      H51-4EDC7908276AD2AA99DD1A70dosing.json
      /records/122/clinical_release_verification/dailymed_search_url      		Historical; current review incomplete
      H51-4B1B378E624BE7F936F31EF0first-look-v5.1.json
      /records/122/id      		Historical; current review incomplete
      H51-6D9A1EB06E7DC3D81D68E1A5first-look-v5.1.json
      /records/122/generic_name      		Historical; current review incomplete
      H51-26302D5CA588492134E9457Cfirst-look-v5.1.json
      /records/122/class      		Historical; current review incomplete
      H51-FCEAFF54EFEE1095316D1396first-look-v5.1.json
      /records/122/subclass      		Historical; current review incomplete
      H51-596CAD04050F648D9844CA0Afirst-look-v5.1.json
      /records/122/primary_uses/0      		Historical; current review incomplete
      H51-9DD0AB286DBC38B6F220D334first-look-v5.1.json
      /records/122/mechanism      		Historical; current review incomplete
      H51-0D4A30B58F2D7FE4B1C066F8first-look-v5.1.json
      /records/122/mechanism_level      		Historical; current review incomplete
      H51-3680D16E6E86D52B92E0A58Efirst-look-v5.1.json
      /records/122/basic_dosing_orientation      		Historical; current review incomplete
      H51-5A2B30430598D817920E3E76first-look-v5.1.json
      /records/122/administration_orientation      		Historical; current review incomplete
      H51-BACB9C45B432FF2B9778B1BFfirst-look-v5.1.json
      /records/122/renal_and_population_orientation      		Historical; current review incomplete
      H51-ADDD5F3803E4193935BECE9Efirst-look-v5.1.json
      /records/122/key_safety_orientation/0      		Historical; current review incomplete
      H51-709196DB5898CA016F83F876first-look-v5.1.json
      /records/122/coverage_path      		Historical; current review incomplete
      H51-FBAA6AE4AE5D315CCFF1012Dfirst-look-v5.1.json
      /records/122/coverage_path_label      		Historical; current review incomplete
      H51-DC1CA3B337D52E7230DA8932first-look-v5.1.json
      /records/122/official_label_url      		Historical; current review incomplete
      H51-54E6C2C9D462B40150B6D029first-look-v5.1.json
      /records/122/legacy_title      		Historical; current review incomplete
      H51-8F8CA484967FBD7C9EC11D91first-look-v5.1.json
      /records/122/review_note      		Historical; current review incomplete
      H51-5124F4A00A2FC3DCFCAD08CEfirst-look-v5.1.json
      /records/122/search_text      		Historical; current review incomplete
      H51-A2B2B244F13CF8BAA7999A24first-look-v5.1.json
      /records/122/official_search_url      		Historical; current review incomplete
      H51-453C9F86E6F698FCF504C688first-look-v5.1.json
      /records/122/official_access_mode      		Historical; current review incomplete
      H51-C3153A78DF0C94E900AEC773first-look-v5.1.json
      /records/122/official_access_url      		Historical; current review incomplete
      H51-2628DBC41CA8DF2CD774E0F7first-look-v5.1.json
      /records/122/official_search_query      		Historical; current review incomplete
      H51-6EDE1D6EF36345E4E3A54BA5first-look-v5.1.json
      /records/122/official_access_reason      		Historical; current review incomplete
      H51-D3951A94293E7C8B720A7B03preparation-assessments-v3.8.json
      /122/id      		Historical; current review incomplete
      H51-B8736EDE542131858EFE7F3Dpreparation-assessments-v3.8.json
      /122/name      		Historical; current review incomplete
      H51-C3D54189310D274A686589A7preparation-assessments-v3.8.json
      /122/brands      		Historical; current review incomplete
      H51-A4DCDEDB53D56971AE8F58F6preparation-assessments-v3.8.json
      /122/therapeutic_class      		Historical; current review incomplete
      H51-F91E31EE26009DA38BB7B533preparation-assessments-v3.8.json
      /122/review_version      		Historical; current review incomplete
      H51-570D558FA7F67B897B645CD9preparation-assessments-v3.8.json
      /122/review_date      		Historical; current review incomplete
      H51-56D1381B60C3C232EDD0181Dpreparation-assessments-v3.8.json
      /122/release_status      		Historical; current review incomplete
      H51-B12FD883A8F824612E59C743preparation-assessments-v3.8.json
      /122/market_status/status      		Historical; current review incomplete
      H51-5349E623C228D9D0A9EDF5C5preparation-assessments-v3.8.json
      /122/market_status/basis      		Historical; current review incomplete
      H51-34976520EC52CC8451D74341preparation-assessments-v3.8.json
      /122/ten_point_assessment/exact_formulation      		Historical; current review incomplete
      H51-88001F7E9F6523858825FA93preparation-assessments-v3.8.json
      /122/ten_point_assessment/reconstitution_concentration      		Historical; current review incomplete
      H51-B83B62718F111A39D0CF24A8preparation-assessments-v3.8.json
      /122/ten_point_assessment/maximum_or_recommended_final_concentration      		Historical; current review incomplete
      H51-0831A5AF2C01D86BE3A7D8F4preparation-assessments-v3.8.json
      /122/ten_point_assessment/appropriate_standardized_containers      		Historical; current review incomplete
      H51-57A274C54B3CC440CC39E9D4preparation-assessments-v3.8.json
      /122/ten_point_assessment/adult_dosing_range      		Historical; current review incomplete
      H51-2C2BB2553E1508640E512136preparation-assessments-v3.8.json
      /122/ten_point_assessment/pediatric_dosing_range      		Historical; current review incomplete
      H51-F46CCA0106378AF8263F7516preparation-assessments-v3.8.json
      /122/ten_point_assessment/neonatal_dosing_range      		Historical; current review incomplete
      H51-13DDC5C381D7214E4238E693preparation-assessments-v3.8.json
      /122/ten_point_assessment/infusion_time      		Historical; current review incomplete
      H51-15F6D387D55B8342502DA78Apreparation-assessments-v3.8.json
      /122/ten_point_assessment/fluid_restriction_alternatives      		Historical; current review incomplete
      H51-41BECC34AA4DFF1C418F3953preparation-assessments-v3.8.json
      /122/ten_point_assessment/current_manufacturer_labeling/setid      		Historical; current review incomplete
      H51-9A49CBF24BC8BABF2DA6C857preparation-assessments-v3.8.json
      /122/ten_point_assessment/current_manufacturer_labeling/title      		Historical; current review incomplete
      H51-6A195E444ADAE8C2FE67CCE4preparation-assessments-v3.8.json
      /122/ten_point_assessment/current_manufacturer_labeling/published_date      		Historical; current review incomplete
      H51-4F2C65238AC00CE77A62E1DDpreparation-assessments-v3.8.json
      /122/ten_point_assessment/current_manufacturer_labeling/manufacturer      		Historical; current review incomplete
      H51-562ED4BC98E51C5EC58D4C0Apreparation-assessments-v3.8.json
      /122/ten_point_assessment/current_manufacturer_labeling/match_confidence      		Historical; current review incomplete
      H51-D2C02443AC094C94984722DCpreparation-assessments-v3.8.json
      /122/ten_point_assessment/current_manufacturer_labeling/url      		Historical; current review incomplete
      H51-AB847D2B9ED9E9BFCDEEB4E3preparation-assessments-v3.8.json
      /122/field_provenance/exact_formulation/primary      		Historical; current review incomplete
      H51-F1C49AD1850DFA3B8984FE5Cpreparation-assessments-v3.8.json
      /122/field_provenance/reconstitution_concentration/primary      		Historical; current review incomplete
      H51-F3A33DD2C0C5606A3CCFCE31preparation-assessments-v3.8.json
      /122/field_provenance/maximum_or_recommended_final_concentration/primary      		Historical; current review incomplete
      H51-94733CF723BE52C1E7B5C721preparation-assessments-v3.8.json
      /122/field_provenance/appropriate_standardized_containers/primary      		Historical; current review incomplete
      H51-48E42E5A860AC568DC1A6C1Apreparation-assessments-v3.8.json
      /122/field_provenance/adult_dosing_range/primary      		Historical; current review incomplete
      H51-DA0FDD80DBFC4A158D42A505preparation-assessments-v3.8.json
      /122/field_provenance/pediatric_dosing_range/primary      		Historical; current review incomplete
      H51-600150C80E37F7ECF723F825preparation-assessments-v3.8.json
      /122/field_provenance/neonatal_dosing_range/primary      		Historical; current review incomplete
      H51-0D1BBFFBC0844D071C6D13C8preparation-assessments-v3.8.json
      /122/field_provenance/infusion_time/primary      		Historical; current review incomplete
      H51-6815A4FDA5D994495156194Bpreparation-assessments-v3.8.json
      /122/field_provenance/fluid_restriction_alternatives/primary      		Historical; current review incomplete
      H51-01F53AED04EE7BEE446866FFpreparation-assessments-v3.8.json
      /122/field_provenance/current_manufacturer_labeling/primary      		Historical; current review incomplete
      H51-4E59DD526DB76395067FE216preparation-assessments-v3.8.json
      /122/population_applicability/adult/applicability      		Historical; current review incomplete
      H51-E0DCAD75B39798FBB315C1ECpreparation-assessments-v3.8.json
      /122/population_applicability/adult/guide_generation_allowed      		Historical; current review incomplete
      H51-B9BF5E633D6C81F575B73B0Cpreparation-assessments-v3.8.json
      /122/population_applicability/pediatric/applicability      		Historical; current review incomplete
      H51-4B498132FD16B13D8E61A835preparation-assessments-v3.8.json
      /122/population_applicability/pediatric/guide_generation_allowed      		Historical; current review incomplete
      H51-B478047EA6625F02AB9A5C26preparation-assessments-v3.8.json
      /122/population_applicability/neonatal/applicability      		Historical; current review incomplete
      H51-30864EA284D9AD14355649C8preparation-assessments-v3.8.json
      /122/population_applicability/neonatal/guide_generation_allowed      		Historical; current review incomplete
      H51-00435B0DBC378310594F2395preparation-assessments-v3.8.json
      /122/route_presence/structured_dilution      		Historical; current review incomplete
      H51-0E41839CAB0E9B3E06811640preparation-assessments-v3.8.json
      /122/route_presence/iv_push      		Historical; current review incomplete
      H51-909C381E8F5FB575FDAFA4ECpreparation-assessments-v3.8.json
      /122/route_presence/continuous_infusion      		Historical; current review incomplete
      H51-4E1404DD3BE2C7D0BAD52E32preparation-assessments-v3.8.json
      /122/route_presence/pediatric_source      		Historical; current review incomplete
      H51-A3B4B11BD6D3B54220A5ADA2preparation-assessments-v3.8.json
      /122/route_presence/neonatal_source      		Historical; current review incomplete
      H51-0516F9EF6D5FB97B8DCCFF67preparation-assessments-v3.8.json
      /122/legacy_reference/status      		Historical; current review incomplete
      H51-DBC98D1F860DD7D6F3A5D035preparation-assessments-v3.8.json
      /122/label_resolution/status      		Historical; current review incomplete
      H51-CAA851C71E42FED6AAB7F745preparation-assessments-v3.8.json
      /122/source_files/0      		Historical; current review incomplete
      H51-AECBB4D7A650262EB6F939A2preparation-assessments-v3.8.json
      /122/source_files/1      		Historical; current review incomplete
      H51-DD486FC38AE3E1B3EC12B517preparation-assessments-v3.8.json
      /122/source_files/2      		Historical; current review incomplete
      H51-20608A3F5BD9EF6114012154preparation-assessments-v3.8.json
      /122/source_files/3      		Historical; current review incomplete
      H51-99ADEAF7C6ACB7D90CFB2FE7preparation-assessments-v3.8.json
      /122/clinical_release_note      		Historical; current review incomplete

      Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)

      All medicationsReturn to medication headingApplication top